Nitroplast (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitroplast, is a nitrate vasodilator presented as an unknown/transdermal patch for transdermal use. It is employed for the prophylaxis of angina pectoris and the management of chronic stable angina in adult patients.

GNH USA supplies Nitroplast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitroplast, a nitrate vasodilator, is used in the treatment of coronary artery disease‑related chest pain. - Prophylaxis of angina pectoris: reduces the frequency of anginal attacks during daily activities. - Management of chronic stable angina: improves exercise tolerance and decreases myocardial oxygen demand. - Ischemic heart disease: alleviates chest pain associated with reduced coronary blood flow.

Nitroplast may cause a range of adverse reactions, most of which are related to its vasodilatory action.

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Flushing: warm sensation and redness of the skin. - Dizziness or light‑headedness: due to transient blood pressure reduction. - Skin irritation at the patch site: erythema or itching.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: fainting episodes caused by abrupt circulatory changes. - Life‑threatening allergic reaction: rash, swelling, or breathing difficulty. - Worsening angina or myocardial infarction: paradoxical increase in chest pain. - Methemoglobinemia: rare disorder impairing oxygen delivery.

When prescribing Nitroplast, clinicians should consider several safety measures. - Severe anemia: avoid use as it may exacerbate hypotension. - Concomitant phosphodiesterase‑5 inhibitors: risk of profound blood pressure fall; avoid combination. - Blood pressure monitoring: check regularly, especially after initiating therapy. - Patch site rotation: change location with each application to minimize skin irritation. - Store at room temperature: keep in original packaging, protect from moisture and light.

Nitroplast can interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Sildenafil, tadalafil, or other PDE‑5 inhibitors: may cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drops. - Alcohol: potentiates hypotensive action.

Moderate Interactions (Monitor Closely): - Antihypertensives such as ACE inhibitors or beta‑blockers: may enhance blood pressure lowering. - Diuretics: increase risk of orthostatic hypotension. - Certain anti‑arrhythmic agents: may require dose adjustments.